Dg Health Clearlax Powder, For Solution
Product Images NDC 55910-306

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dg Health Clearlax (NDC 55910-306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dolgencorp, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Export 00

Export 00
MiraLAX is a laxative powder that relieves occasional constipation and softens stool. It contains polyethylene glycol 3350 as its active ingredient and is generally effective in producing a bowel movement within 1-3 days. This product comes in a bottle with a measuring cap, and one dose should not exceed 17 grams. It should not be taken by individuals who are allergic to polyethylene glycol and those with bowel disease. To prevent overdose, consult with a doctor or a pharmacist before using MiraLAX. If there are unusual symptoms such as diarrhea, nausea or abdominal pain, report and seek medical attention. MiraLAX is safe for persons age 17 and older and should be kept out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.